证券代码：603119 证券简称：浙江荣泰 公告编号：2025-058 浙江荣泰电工器材股份有限公司 股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重点内容提示： 浙江荣泰电工器材股份有限公司(以下简称"公司"或"浙江荣泰")股 票于 2025 年 7 月 15 日、2025 年 7 月 16 日、2025 年 7 月 17 日连续 3 个交易日 内收盘价格涨幅偏离值累计超过 20%，根据《上海证券交易所交易规则》的有关 规定，属于股票交易异常波动情形。 经公司自查并向控股股东及实际控制人核实，截至本公告披露日，公司 控股股东及实际控制人均不存在应披露而未披露的重大事项。 敬请广大投资者注意二级市场交易风险，理性决策，审慎投资。 （一）生产经营情况 经公司自查，目前公司的生产经营活动保持正常运作，财务状况稳健，现金 流状况良好，内外部经营环境未发生重大变化。公司拟于 2025 年 8 月 30 日披露 《2025 年半年度报告》，具体经营情况及财务数据请关注公司定期报告。 （二）重大事项情况 经公司自查 ...

Market Overview - The A-share market opened slightly lower on July 17 but then experienced a rebound, with all three major indices showing positive performance, particularly the ChiNext index which rose nearly 1% [2] - The total market capitalization reached 14.20 trillion CNY, with a trading volume of 7698.06 million hands and a turnover rate of 1.46% [3] Pharmaceutical Sector - The pharmaceutical sector saw a significant surge, with multiple stocks hitting the daily limit up, including Weikang Pharmaceutical and Chengdu Xian Dao, both reaching a 20% increase [4][5] - Notable stocks in the pharmaceutical sector included: - Chengdu Xian Dao: 21.46 CNY, up 20.02% - Weikang Pharmaceutical: 20.71 CNY, up 19.99% - Other stocks like Lifespring Pharmaceutical and Zhejiang Zhenyuan also saw increases of around 10% [5][6] - The Hong Kong pharmaceutical and biotechnology sector also experienced notable gains, with companies like Fudan Zhangjiang and Kanyin Biotech showing significant price increases [6] Robotics Sector - The humanoid robot concept stocks remained active, with Nanjing Julong hitting the daily limit up of 20%, and other companies like Dongshan Precision and Taijing Technology also seeing substantial gains [7][8] - On July 17, the stock of Aowei New Materials achieved a 20% limit up, marking its seventh consecutive trading day of gains, with a closing price of 27.89 CNY [10][11] Policy Impact - The National Healthcare Security Administration recently announced the initiation of the 11th batch of centralized drug procurement, which will include 55 drug varieties, focusing on mature "old drugs" while excluding innovative drugs from the procurement list [6]

Market Overview - A-shares maintained a narrow fluctuation on July 16, with the Shanghai Composite Index closing at 3503.78 points, down 0.03% [1] - The Shenzhen Component Index and the ChiNext Index both fell by 0.22% to 10720.81 points and 2230.19 points, respectively [1] - The total trading volume in the Shanghai and Shenzhen markets was 146.19 billion yuan, a decrease of over 170 billion yuan from the previous day [1] Sector Performance - Financial stocks collectively declined, while the steel, non-ferrous metals, and coal sectors showed weakness [1] - The automotive supply chain stocks surged, with companies like Rongtai Co., Fuda Co., and Zhejiang Rongtai hitting the daily limit [1] - The innovative drug concept saw significant activity, with stocks like Guosheng Tang and Iwu Biotech rising approximately 16% [5][6] - The humanoid robot concept remained hot, with companies like Shangwei New Materials achieving a six-day limit increase [2][4] Notable Company Movements - Huadian New Energy, which debuted on the Shanghai main board, closed up 125.8%, reaching a market value of over 300 billion yuan at one point [1] - Weiyali, a Hong Kong-based electronic component distributor, saw its stock surge by 288% upon resuming trading, with an intraday increase exceeding 900% [1] Humanoid Robot Sector Insights - The humanoid robot industry is in its early stages, with significant growth expected in the next 3 to 5 years across various applications [4] - The current phase is described as the "dawn" of humanoid robot industrialization, with mass production and large-scale application becoming feasible [4] - Cost reduction is crucial for the widespread adoption of humanoid robots, and companies that master core component technologies are recommended for investment [4] Innovative Drug Sector Insights - The innovative drug sector experienced strong gains, with several companies hitting the daily limit [5][6] - The recent launch of the 11th batch of national drug centralized procurement is expected to impact the market, focusing on mature "old drugs" rather than innovative drugs [7] - The introduction of measures to support the high-quality development of innovative drugs indicates a growing role for commercial insurance in the healthcare system [7] Pet Economy Sector Insights - The pet economy concept gained traction, with companies like Weike Technology rising over 10% [8] - The pet food sector is viewed as a growing market with significant long-term growth potential, particularly for domestic brands [8]

Core Viewpoint - The market is currently experiencing structural opportunities, particularly with a "seesaw" phenomenon between technology stocks and high-dividend assets, as technology stocks strengthen while bank sector high-dividend assets undergo a correction [1]. Group 1: Technology Stocks and AI - Technology stocks, especially in the AI sector, have shown significant strength, with hardware and application segments both rising, leading to a boost in the TMT (Technology, Media, and Telecommunications) sector [1]. - Notable stocks in the AI sector include New Yi Sheng (300502), which rose by 11.69%, and Zhong Ji Xu Chuang (300308), which increased by 1.54%, with trading volumes of 130 billion and 101.7 billion respectively, ranking first and second in A-shares [1]. - The human-shaped robot and innovative drug sectors are also experiencing a rebound, with stocks like Wang Wei New Material and Rong Tai Co. seeing significant gains [1]. Group 2: Human-shaped Robots - The human-shaped robot sector has rebounded significantly, positively impacting the overall market, with multiple related sectors such as PEEK materials, motors, automotive parts, and industrial mother machines also rising [4]. - Key stocks in this sector include Rong Tai Co. (605133) and Zhejiang Rong Tai (603119), both hitting the daily limit up with increases of 10.01% and 10.00% respectively [6][5]. - The industry is in a relatively early stage, with expectations for broader applications in service, household, industrial, and rescue scenarios over the next 3 to 5 years, despite facing challenges in large-scale application [8]. Group 3: New Consumption Trends - The new consumption sectors, including the "Guzi Economy," pet economy, and beauty care, have collectively risen, indicating a rebound in consumer spending [10]. - In the "Guzi Economy," stocks like Tian Di Online and Hengdian Film & Television hit the daily limit up, reflecting strong market interest [10]. - The pet economy is also thriving, with Lan Sheng Co. hitting the daily limit up, supported by a growing pet ownership trend in urban areas, projected to reach 120 million pets by 2024 [14]. Group 4: Market Dynamics - The overall market is characterized by index fluctuations while individual stocks are performing strongly, particularly in AI, human-shaped robots, and innovative drugs [1]. - The market sentiment is shifting towards higher risk appetite, driven by the performance of technology stocks and emerging sectors [1].

一、监事会会议召开情况 浙江荣泰电工器材股份有限公司（以下简称"公司"）第二届监事会第七次 会议的通知及资料已于2025年7月9日以电话、邮件等方式送达至全体监事，并于 集并主持，会议应参会监事3人，实际参会监事3人，公司董事会秘书列席了本次 会议。本次会议的召开符合《公司法》和《公司章程》的有关规定，会议合法有 效。 二、监事会会议审议情况 (一)审议通过了《关于部分募投项目延期的议案》 监事会认为：公司本次关于部分募投项目延期的事项符合公司募集资金投资 项目实际情况，不影响募投项目的实施，不存在变相改变募集资金用途和损害股 东利益的情形，符合中国证监会、上海证券交易所关于上市公司募集资金管理的 有关规定，符合公司及全体股东的利益，也有利于公司的长远发展。因此，同意 公司将部分募投项目进行延期。 证券代码：603119 证券简称：浙江荣泰 公告编号：2025-055 浙江荣泰电工器材股份有限公司 第二届监事会第七次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 表决结果：3名赞成；0名反对；0名弃权。 具体内容 ...

浙江荣泰电工器材股份有限公司 关于收购广东金力智能传动技术股份有限公司 15%股份的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 浙江荣泰电工器材股份有限公司（以下简称"公司"）通过增资方式， 以 27.03 元/股价格，以人民币 10,065.9720 万元（"增资款"）认缴广东金力智 能传动技术股份有限公司（以下简称"金力传动"或"目标公司"）新增的 372.4 万元注册资本，对应本次增资后持有目标公司 5.03%的股份，增资款中人民币 9,693.5720 万元计入资本公积。同时，通过股份转让的方式受让目标公司股东合 计持有的 737.3 万股股份，转让金额合计为人民币 19,933.643 万元。上述增资及 股份转让完成后，目标公司注册资本变更为 7,398.00 万元，公司持有目标公司 15%股份。 本次交易不构成关联交易，也不构成《上市公司重大资产重组管理办法》 规定的重大资产重组。 证券代码：603119 证券简称：浙江荣泰 公告编号：2025-056 本次交易经公司第二届董事会第九次会议 ...

证券代码：603119 证券简称：浙江荣泰 公告编号：2025-057 浙江荣泰电工器材股份有限公司 关于部分募投项目延期的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 浙江荣泰电工器材股份有限公司（以下简称"公司"）于 2025 年 7 月 14 日召开第二届董事会第九次会议、第二届监事会第七次会议，审议通过了《关于 部分募投项目延期的议案》。根据公司募集资金投资项目（以下简称"募投项目"） 的实际建设情况，同意公司在募投项目实施主体、实施方式、募集资金投资用途 及投资规模不发生变更的前提下，将募投项目"湖南荣泰年产 1.5 万吨新能源用 云母制品生产项目"达到预定可使用状态日期延期至 2026 年 12 月。具体情况如 下： 一、募集资金的基本情况 根据中国证券监督管理委员会《关于同意浙江荣泰电工器材股份有限公司首 次公开发行股票注册的批复》（证监许可[2023]1288 号），公司首次公开发行 人民币普通股（A 股）股票 7,000.00 万股，每股发行价格为 15.32 元，募集资金 总额为 107,240.0 ...

浙江荣泰电工器材股份有限公司（以下简称"公司"）第二届监事会第七次 会议的通知及资料已于2025年7月9日以电话、邮件等方式送达至全体监事，并于 2025年7月14日14:00在公司会议室以现场的方式召开。会议由监事会主席饶蕾召 集并主持，会议应参会监事3人，实际参会监事3人，公司董事会秘书列席了本次 会议。本次会议的召开符合《公司法》和《公司章程》的有关规定，会议合法有 效。 证券代码：603119 证券简称：浙江荣泰 公告编号：2025-055 浙江荣泰电工器材股份有限公司 第二届监事会第七次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、监事会会议召开情况 具体内容详见公司于同日在上海证券交易所网站披露的《浙江荣泰电工器材 股份有限公司关于部分募投项目延期的公告》。（公告编号：2025-057） 特此公告。 浙江荣泰电工器材股份有限公司监事会 2025 年 7 月 15 日 二、监事会会议审议情况 (一)审议通过了《关于部分募投项目延期的议案》 监事会认为：公司本次关于部分募投项目延期的事项符合公司募集 ...

证券代码：603119 证券简称：浙江荣泰 公告编号：2025-054 浙江荣泰电工器材股份有限公司（以下简称"公司"）第二届董事会第九次 会议的通知及资料已于 2025 年 7 月 9 日以电话、邮件等方式送达至全体董事， 并于 2025 年 7 月 14 日 10：00 在公司会议室以现场结合通讯的方式召开。会议 由董事长曹梅盛召集并主持，会议应参会董事 7 人，实际参会董事 7 人，公司全 体监事、高级管理人员列席了本次会议。 本次会议的召开符合《公司法》和《公司章程》的有关规定，会议合法有效。 浙江荣泰电工器材股份有限公司 第二届董事会第九次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 (二)审议通过了《关于部分募投项目延期的议案》 表决结果：7 名赞成；0 名反对；0 名弃权。 二、董事会会议审议情况 (一)审议通过了《关于收购广东金力智能传动技术股份有限公司 15%股份的 议案》 表决结果：7 名赞成；0 名反对；0 名弃权。 此事项已经公司第二届董事会独立董事专门会议第二次 ...

本报告依据中国资产评估准则编制 浙江荣泰电工器材股份有限公司 拟收购股权涉及的 广东金力智能传动技术股份有限公司 股东全部权益投资价值 资产评估报告 天源评报字〔 2025 〕第 0714 号 共一册 第一册 大 中国资产评估协会 资产评估业务报告备案回执 | 报告编码: | 3333020139202500466 | | --- | --- | | 合同编号: | 1000107363 | | 报告类型: | 非法定评估业务资产评估报告 | | 报告文号: | 天源评报字[2025]第0714号 | | 报告名称: | 浙江荣泰电工器材股份有限公司拟收购股权涉及的广东金力智能 传动技术股份有限公司股东全部权益投资价值资产评估报告 | | 评估结论: | 1,913,230,000.00元 | | 评估报告日: | 2025年07月11日: | | 评估机构名称: | 天源资产评估有限公司 | | 签名人员: | 刘 小明 (资产评估师) 正式会员 编号:33180129 | | | 黄伟 资产评估师) 正式会员 编号:31220036 | | | 《刘小明、黄伟已实名认可 | | | (可扫描二维码查询备案 ...